(Q42633058)

4 November 2017

Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study (English)

1 reference

4 November 2017

0 references

D I Kaufer

1

1 reference

PubMed ID

8679057

4 November 2017

J L Cummings

series ordinal

2

1 reference

PubMed ID

8679057

4 November 2017

D Christine

series ordinal

3

1 reference

4 November 2017

1 January 1996

1 reference

Journal of Geriatric Psychiatry and Neurology

4 November 2017

1 reference

4 November 2017

9

1 reference

4 November 2017

1-6

1 reference

4 November 2017

1

1 reference

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

4 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

Cholinergic function and intellectual decline in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

The cholinergic hypothesis of geriatric memory dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

The cholinergic hypothesis--ten years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

Oral physostigmine as treatment for primary degenerative dementia: a double-blind placebo-controlled inpatient trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

Tacrine in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

Intraventricular bethanechol infusion for Alzheimer's disease: results of double-blind and escalating-dose trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

Physostigmine ameliorates the delusions of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

A new rating scale for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

The Stockton Geriatric Rating Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: two sides of the same coin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

The role of interactions between the cholinergic system and other neuromodulatory systems in learing and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

Tetrahydroaminoacridine inhibits human and rat brain monoamine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879600900101

10.1177/089198879600900101

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference

PubMed ID

8679057